Chemical Compound
Ritonavir 4-hydroxy isomer
CAS Registry Number
202816-62-4
Primary Record
Ritonavir 4-hydroxy isomer
- In stock
- 6,733 g
- Purity
- 99.0 %
- CAS
- 202816-62-4
Compound Identifiers & Properties
- CAS
- 202816-62-4
- PubChem CID
- 515815
- SMILES
- CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
- Canonical SMILES
- CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)[C@@H](O)C[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1
Names & Synonyms
- Ritonavir 4-hydroxy isomer
- 4-Dehydroxy-5-hydroxy Ritonavir
- Ritonavir EP Impurity N
- Ritonavir impurity N
- UNII-QA8V47KHDS
- Ritonavir Impurity I
- QA8V47KHDS
- Ritonavir impurity N [EP]
- AC1LALA2
- 202816-62-4
- RefChem:179515
- DTXSID40174138
- DTXCID2096629
- SCHEMBL13265657
- (5S,8S,9S,11S)-9-Hydr
- AIDS192409
- CID515815
- ZINC27719506
- RITONAVIR IMPURITY N [EP IMPURITY]
- Ritonavir impurity, 4-hydroxy isomer- [USP]
- RITONAVIR IMPURITY N (EP IMPURITY)
- Ritonavir impurity, 4-hydroxy isomer-(USP)
- Ritonavir impurity, 4-hydroxy isomer-[USP]
- 1,3-thiazol-5-ylmethyl N-[(2S,4S,5S)-4-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
- Q27287166
- 2,7,10,12-Tetraazatridecanoic acid, 5-hydroxy-12-methyl-9-(1-methylethyl)-13-(2-(1-methylethyl)-4-thiazolyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,5S,6S,9S)-
- Thiazol-5-ylmethyl ((1S,3S,4S)-1-benzyl-3-hydroxy-4-(((2S)-3-methyl-2-((methyl((2-(1-methylethyl)thiazol-4-yl)methyl)carbamoyl)amino)butanoyl)amino)-5-phenylpentyl)carbamate
- Thiazol-5-ylmethyl (2S,4S,5S)-4-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate
- RITONAVIR IMPURITY, 4-HYDROXY ISOMER-(USP IMPURITY)
- RITONAVIR IMPURITY, 4-HYDROXY ISOMER-[USP IMPURITY]
- RITONAVIR IMPURITY, 4-HYDROXY ISOMER- [USP IMPURITY]
- Thiazol-5-ylmethyl ((2S,4S,5S)-4-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate
- (3S,5S,6S,9S)-5-Hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-Thiazolylmethyl Ester
- (5S,8S,9S,11S)-9-Hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic Acid 5-Thiazolylmethyl Ester
- 2,7,10,12-Tetraazatridecanoic acid, 5-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,5S,6S,9S)-; 2,4,7,12-Tetraazatridecan-13-oic acid, 9-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S,8S,9S,11S)- (9CI); 2,4,7,12-Tetraazatridecan-13-oic acid, 9-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, [5S-(5R*,8R*,9R*,11R*)]-; Ritonavir Imp. N (EP)
- N-[(2S,3S,5S)-3-Hydroxy-1,6-diphenyl-5-({[(1,3-thiazol-5-yl)methoxy]carbonyl}amino)hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
- N1-((1S,2S,4S)-1-Benzyl-2-hydroxy-5-phenyl-4-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}pentyl)-N2-{[[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)amino]carbonyl}-L-valinamide
- thiazol-5-ylmethyl N-[(1S,3S,4S)-1-benzyl-3-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate